User profiles for Santiago Barrio
 | Santiago Fabregat BarriosUniversidad de Jaén Verified email at ujaen.es Cited by 789 |
[BOOK][B] Morfología léxica: la formación de palabras
SV Ortega, SF Barrios - 2005 - academia.edu
… En la primera fase de redacción de este libro recabé la asistencia de Santiago Fabregat
quien, por su familiaridad con la Enseñanza Secundaria, me fue indicando aquellas partes …
quien, por su familiaridad con la Enseñanza Secundaria, me fue indicando aquellas partes …
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
…, F Pepin, M González, S Barrio… - Blood, The Journal …, 2014 - ashpublications.org
We assessed the prognostic value of minimal residual disease (MRD) detection in multiple
myeloma (MM) patients using a sequencing-based platform in bone marrow samples from …
myeloma (MM) patients using a sequencing-based platform in bone marrow samples from …
[HTML][HTML] Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels
…, R Laguna-Goya, G Carreño-Tarragona, S Barrio… - MedRxiv, 2020 - ncbi.nlm.nih.gov
T cells are involved in the early identification and clearance of viral infections and also
support the development of antibodies by B cells. This central role for T cells makes them a …
support the development of antibodies by B cells. This central role for T cells makes them a …
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes
…, CX Shi, YX Zhu, L Bruins, S Barrio… - Blood, The Journal …, 2016 - ashpublications.org
In this study, targeted sequencing to screen 50 multidrug refractory multiple myeloma (rMM)
patients was performed by using the Multiple Myeloma Mutation Panel. Patients were …
patients was performed by using the Multiple Myeloma Mutation Panel. Patients were …
[HTML][HTML] A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2
…, K Dobbs, G Carreño-Tarragona, S Barrio… - Research …, 2020 - ncbi.nlm.nih.gov
We describe the establishment and current content of the ImmuneCODE™ database, which
includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects …
includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects …
[HTML][HTML] The minimal residual disease using liquid biopsies in hematological malignancies
R Colmenares, N Álvarez, S Barrio, J Martínez-López… - Cancers, 2022 - mdpi.com
Simple Summary Monitoring the response to treatment in hematologic malignancies is
essential in defining the best way to optimize patient management. In general, achieving a …
essential in defining the best way to optimize patient management. In general, achieving a …
Spectrum and functional validation of PSMB5 mutations in multiple myeloma
S Barrio, T Stühmer, M Da-Viá, C Barrio-Garcia… - Leukemia, 2019 - nature.com
Despite an increasing number of approved therapies, multiple myeloma (MM) remains an
incurable disease and only a small number of patients achieve prolonged disease control. …
incurable disease and only a small number of patients achieve prolonged disease control. …
[HTML][HTML] IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma
S Barrio, U Munawar, YX Zhu, N Giesen, CX Shi… - …, 2020 - ncbi.nlm.nih.gov
Cereblon (CRBN), a target of immunomodulatory drugs (IMiD), forms the CRL4CRBN E3
ubiquitin ligase (CRL4) complex with DDB1, CUL4B and ROC1. 1, 2 Under the influence of …
ubiquitin ligase (CRL4) complex with DDB1, CUL4B and ROC1. 1, 2 Under the influence of …
[HTML][HTML] Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma
J Martinez-Lopez, B Sanchez-Vega, S Barrio, I Cuenca… - Leukemia, 2017 - nature.com
3 Cai X, Gao L, Teng L, Ge J, Oo ZM, Kumar AR et al. Runx1 deficiency decreases ribosome
biogenesis and confers stress resistance to hematopoietic stem and progenitor cells. Cell …
biogenesis and confers stress resistance to hematopoietic stem and progenitor cells. Cell …
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous …
…, AG Solimando, A Garitano‐Trojaola, S Barrio… - The …, 2020 - academic.oup.com
BRAF mutations constitute an attractive druggable target in multiple myeloma. This is the
first genomic dissection of the central nervous system involvement in a multiple myeloma …
first genomic dissection of the central nervous system involvement in a multiple myeloma …